Ventas, Inc.

VTR 10-K · Q4 2025

VTR Q4 2025 request

Playground key active
Request URL /api/financials?ticker=VTR&year=2025&quarter=4
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q4 2025 Q4 2024 YoY
Operating Lease Lease Income 359,469 373,602 -3.8%
Show Product Lines breakouts
NNN 132,713 157,403 -15.7%
Outpatient medical and research portfolio (OM&R) 226,756 216,199 +4.9%
Show Business Segments breakouts
NNN · Operating Segments 132,713 157,403 -15.7%
Outpatient medical and research portfolio (OM&R) · Operating Segments 226,756 216,199 +4.9%
Revenue (Q)
Show Product Lines breakouts
Management Service 3.8 3.8 -0.0%
Third-party capital management revenues 4,322 4,339 -0.4%
Third-party capital management revenues · Corporate Non Segment 3,543 3,588 -1.3%
Third-party capital management revenues · Outpatient medical and research portfolio (OM&R) 779 751 +3.7%
Interest And Other Income 7,877 8,305 -5.2%
Show Consolidation Items breakouts
Corporate Non Segment 7,877 8,305 -5.2%
Revenue 1,566,017 1,287,057 +21.7%
Show Business Segments breakouts
NNN · Operating Segments 132,713 157,403 -15.7%
Outpatient medical and research portfolio (OM&R) · Operating Segments 227,535 216,950 +4.9%
Show — breakouts
Revenue 1,185,999 896,360 +32.3%
Show Consolidation Items breakouts
Corporate Non Segment 19,770 16,344 +21.0%
Interest Expense 154,468 153,206 +0.8%
Depreciation And Amortization 352,723 308,772 +14.2%
Direct Costs Of Leased And Rented Property Or Equipment 935,786 739,506 +26.5%
Show Product Lines breakouts
NNN 3,000 4,206 -28.7%
Outpatient medical and research portfolio (OM&R) 77,639 73,617 +5.5%
Show Business Segments breakouts
NNN · Operating Segments 3,000 4,206 -28.7%
Outpatient medical and research portfolio (OM&R) · Operating Segments 77,639 73,617 +5.5%
Show — breakouts
Direct Costs Of Leased And Rented Property Or Equipment 855,147 661,683 +29.2%
Direct Costs Of Leased And Rented Property Or Equipment 855,147 661,683 +29.2%
Cost Of Other Property Operating Expense 1,610 1,551 +3.8%
General & Administrative 41,008 41,434 -1.0%
Gains Losses On Extinguishment Of Debt 53 15 +253.3%
Business Combination Acquisition Related Costs -6,008 4,226 -242.2%
Total Costs & Expenses 1,489,731 1,287,565 +15.7%
Income Before Taxes 76,286 -508 +15116.9%
Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree -7,727 6,969 -210.9%
Gain Loss On Disposition Of Real Estate 3,311 6,727 -50.8%
Income Tax Expense (Benefit) 1,122 45,539 -97.5%
Net Income 72,992 58,727 +24.3%
Show Equity Components breakouts
Parent 70,202 56,835 +23.5%
Retained Earnings 70,202 56,835 +23.5%
Net Income Loss Attributable To Noncontrolling Interest 2,790 1,892 +47.5%
Net Income Loss Available To Common Stockholders Basic 70,202 56,835 +23.5%
Income Loss From Continuing Operations Per Basic Share 0.15 0.14 +7.1%
EPS (Basic) 0.15 0.14 +7.1%
Income Loss From Continuing Operations Per Diluted Share 0.16 0.14 +14.3%
EPS (Diluted) 0.14 0.13 +7.7%
Comprehensive Income 68,141 61,782 +10.3%
Wtd Avg Shares (Basic) 5,510 3,079 +79.0%
Wtd Avg Shares (Diluted) 6,223 3,581 +73.8%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 741,067 897,850 -17.5%
Non-Current Assets
Operating Lease Right-of-Use Assets 295,838 308,019 -4.0%
Goodwill 1,046,072 1,044,915 +0.1%
Show Business Segments breakouts
NNN 319,569
Outpatient medical and research portfolio (OM&R) 466,967
SHOP 259,536
Deferred Tax Assets 2,797 1,931 +44.8%
Total Assets 27,591,945 26,186,906 +5.4%
Show Legal Entity breakouts
Fonds Immobilier Groupe Maurice, S.E.C. · Variable Interest Entity Primary Beneficiary 1,822,300 1,779,762 +2.4%
NHP/PMB L.P. · Variable Interest Entity Primary Beneficiary 656,813 728,457 -9.8%
Other identified VIEs · Variable Interest Entity Primary Beneficiary 1,469,659 1,447,381 +1.5%
Show Real Estate Properties breakouts
Unconsolidated Properties 9,991,116 9,813,724 +1.8%
Other Assets
Investment Building And Building Improvements 30,872,598 28,717,990 +7.5%
Finite Lived Intangible Assets Gross 1,680,567 1,558,751 +7.8%
Show Finite Lived Intangible Assets By Major Class breakouts
Above Market Leases 120,178 124,515 -3.5%
In-place and other lease intangibles 1,560,389 1,434,236 +8.8%
Real Estate Investment Property At Cost 36,170,552 33,696,781 +7.3%
Real Estate Investment Property Net 24,126,933 22,600,545 +6.8%
Show Geography breakouts
CA 2,783,873 2,719,078 +2.4%
GB 205,060 190,629 +7.6%
US 21,138,000 19,690,838 +7.3%
Secured Notes And Loans Receivable Net 143,913 144,872 -0.7%
Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures 617,571 626,122 -1.4%
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
All other · Unconsolidated Properties 581 601 -3.3%
Atrium Health & Wake Forest Joint Venture · Unconsolidated Properties 39,809 36,881 +7.9%
Pension Fund Joint Venture · Unconsolidated Properties 6,200 11,939 -48.1%
R&I JV [Member] · Unconsolidated Properties 282,512 309,499 -8.7%
The Fund [Member] · Unconsolidated Properties 288,469 267,202 +8.0%
Ventas Investment Management platform · Unconsolidated Properties 577,181 588,640 -1.9%
Real Estate Investments 24,888,417 23,371,539 +6.5%
Escrowdepositsandrestrictedcash 45,070 59,383 -24.1%
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 45,070 59,383 -24.1%
Estimate Of Fair Value Fair Value Disclosure 45,070 59,383 -24.1%
Assets Of Disposal Group Including Discontinued Operation 42,993 18,625 +130.8%
Show Business Segments breakouts
NNN 22,188
Outpatient Medical Buildings And Other 468 13 +3500.0%
SHOP 20,337 18,612 +9.3%
Other Assets 825,529 792,663 +4.1%
Non-Current Liabilities
Interest Payable Current And Noncurrent 143,104 143,345 -0.2%
Accounts Payable And Accrued Liabilities Current And Noncurrent 1,240,820 1,152,306 +7.7%
Deferred Tax Liabilities 23,409 8,150 +187.2%
Total Liabilities 14,630,983 15,047,081 -2.8%
Show Legal Entity breakouts
Fonds Immobilier Groupe Maurice, S.E.C. · Variable Interest Entity Primary Beneficiary 1,151,437 1,121,659 +2.7%
NHP/PMB L.P. · Variable Interest Entity Primary Beneficiary 235,245 286,030 -17.8%
Other identified VIEs · Variable Interest Entity Primary Beneficiary 467,665 410,721 +13.9%
Show Real Estate Properties breakouts
Unconsolidated Properties 6,228,827 6,168,639 +1.0%
Long-Term Debt 13,011,016 13,522,551 -3.8%
Other Liabilities
Longtermdebtandshorttermborrowings 13,011,016 13,522,551 -3.8%
Operating Lease Liability 208,602 218,003 -4.3%
Liabilities Of Disposal Group Including Discontinued Operation 4,032 2,726 +47.9%
Show Business Segments breakouts
NNN 1,116
Outpatient Medical Buildings And Other 130 568 -77.1%
SHOP 2,786 2,158 +29.1%
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests 375,154 310,229 +20.9%
Show Equity Components breakouts
Noncontrolling Interest 114,482 109,809 +4.3%
Show Partner Type Of Partners Capital Account breakouts
General Partner 260,672 200,420 +30.1%
Stockholders' Equity
Common Stock 118,732 109,119 +8.8%
Additional Paid In Capital Common Stock 19,976,183 17,607,482 +13.5%
Accumulated Other Comprehensive Income -39,851 -33,526 -18.9%
Retained Earnings -7,527,777 -6,886,653 -9.3%
Treasury Stock Value -34 -25,155 +99.9%
Total Stockholders' Equity 12,527,253 10,771,267 +16.3%
Show Real Estate Properties breakouts
Unconsolidated Properties 3,256,420 3,062,405 +6.3%
Minority Interest 58,555 58,329 +0.4%
Show Real Estate Properties breakouts
Unconsolidated Properties 505,869 582,678 -13.2%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 12,585,808 10,829,596 +16.2%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -39,851 -33,526 -18.9%
Additional Paid In Capital 19,976,183 17,607,482 +13.5%
Common Stock 118,732 109,119 +8.8%
Noncontrolling Interest 58,555 58,329 +0.4%
Parent 12,527,253 10,771,267 +16.3%
Retained Earnings -7,527,777 -6,886,653 -9.3%
Treasury Stock Common -34 -25,155 +99.9%
Total Liabilities & Equity 27,591,945 26,186,906 +5.4%
Land 2,962,738 2,775,790 +6.7%
Construction In Progress Gross 358,811 336,231 +6.7%
Accumulateddepreciationandamortization -12,043,619 -11,096,236 -8.5%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Other Amortization Of Deferred Charges 9,844 7,796 +26.3%
Stock-Based Compensation 6,318 4,647 +36.0%
Straight Line Rent -10,068 1,375 -832.2%
Extinguishment Of Debt Gain Loss Net Of Tax 53 15 +253.3%
Other Tax Expense Benefit -2,148 -46,022 +95.3%
Equity Method Investment Dividends Or Distributions 7,292 4,659 +56.5%
Other Non-Cash Items 3,246 25,081 -87.1%
Increase Decrease In Other Operating Assets -16,168 5,041 -420.7%
Increase Decrease In Interest Payable Net 29,638 30,620 -3.2%
Increase Decrease In Accounts Payable And Accrued Liabilities 21,763 -326 +6775.8%
Net Cash from Operations 471,663 373,641 +26.2%
Investing Activities
Payments To Acquire Loans Receivable -69 -4,668 +98.5%
Proceeds From Sale Of Real Estate Heldforinvestment 54,392 53,698 +1.3%
Proceeds From Sale And Collection Of Loans Receivable 39,383 374 +10430.2%
Payments To Develop Real Estate Assets -96,340 -82,668 -16.5%
Payments To Acquire Equity Method Investments -15,628 -14,294 -9.3%
Proceeds From Insurance Settlement Investing Activities 2,071 19 +10800.0%
Net Cash from Investing -428,722 -1,536,214 +72.1%
Financing Activities
Proceeds From Repayments Of Lines Of Credit 0 -952 +100.0%
Proceeds From Issuance Of Debt 523,647 107,985 +384.9%
Repayments Of Other Debt -128,111 -81,447 -57.3%
Payments Of Financing Costs -4,928 -1,194 -312.7%
Proceeds From Issuance Of Common Stock 279,460 1,114,306 -74.9%
Payments Of Dividends Common Stock -225,684 -188,957 -19.4%
Proceeds From Minority Shareholders 0 57 -100.0%
Payments To Minority Shareholders -5,086 -8,160 +37.7%
Proceeds From Stock Options Exercised 65,212 15,569 +318.9%
Proceeds From Payments For Other Financing Activities -2,868 1,246 -330.2%
Net Cash from Financing 499,856 956,201 -47.7%
Supplemental
Income Taxes Paid -1,056 427 -347.3%
Other Cash Flow
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 542,797 -206,372 +363.0%
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 789 -2,092 +137.7%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 786,137 957,233 -17.9%
Transfer Of Investments 1,549 32,623 -95.3%
Noncash Or Part Noncash Acquisition Other Assets Acquired1 1,335 11,784 -88.7%
Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed 73,702 21,613 +241.0%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key